| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03279861 Details | 2023-05-06 Interventional | 4 | 0 | Sacubitril and … Valsartan Heart Failure Congestive Hear… Hypertension | protocol change - | |||
| NCT02761694 Details | 2023-05-06 Interventional | 1 | [1 Refs] | 78 | Fulvestrant Paclitaxel Neoplasms Cancer Solid Tumors | Business Reasons - | ||
| NCT01814813 Details | 2023-05-06 Interventional | 2 | 90 | Bevacizumab Glioblastoma Gliosarcoma Recurrence Recurrent Adult… Recurrent Gliob… | DSMB futility analysis - | |||
| NCT05249569 Details | 2023-05-03 Interventional | 2 | 1 | Avelumab Axitinib Bavituximab Carcinoma Carcinoma, Hepa… Hepatocellular … | Sponsor pulled support for one of the study drugs. - | |||
| NCT03776864 Details | 2023-05-03 Interventional | 2 | 6 | Immunoglobulin … Immunoglobulins Pembrolizumab Hodgkin Disease Lymphoma Hodgkin's Lymph… | Company providing drug terminated their oncology program - | |||
| NCT01734694 Details | 2023-05-03 Interventional | 4 | 100 | Ceftaroline Daptomycin Linezolid Vancomycin Arthritis, Infe… Bacteremia Endocarditis Healthcare-Asso… Osteomyelitis Acute Bacterial… Health Care Ass… Osteomyelitis/S… | Independent biostatistician recommended early termination of the trial due to low probability
of success. - | |||
| NCT05109650 Details | 2023-05-01 Interventional | 1 | 13 | Antibodies Immunoglobulins Pharmaceutical … Neoplasms Advanced Solid … | Considering that the high budget will affect the subsequent development, it is decided to
terminate the test voluntarily - | |||
| NCT05032118 Details | 2023-05-01 Interventional | 2/3 | 0 | Ketamine Propofol Hemorrhage Subarachnoid He… Subarachnoid He… | Institution change, no IRB approval - | |||
| NCT02376699 Details | 2023-05-01 Interventional | 1 | 159 | Gemcitabine Paclitaxel Pembrolizumab Carcinoma Carcinoma, Non-… Carcinoma, Squa… Head and Neck N… Hodgkin Disease Lung Neoplasms Lymphoma Lymphoma, B-Cel… Lymphoma, Folli… Lymphoma, Large… Lymphoma, Non-H… Neoplasm Metast… Neoplasms Neoplasms, Squa… Squamous Cell C… Melanoma Neoplasms, Head… Non-Small Cell … Non-Small Cell … Non-small Cell … Pancreatic Aden… Squamous Cell C… Squamous Cell C… Squamous Cell C… Squamous Cell N… | Study closed due to portfolio prioritization - | |||
| NCT01333514 Details | 2023-05-01 Interventional | 4 | [3 Refs] | 14 | Insulin Aspart Insulin deglude… Insulin, Long-A… Diabetes | - Early termination due to the PI becoming sick early in the study. | ||
| NCT04879589 Details | 2023-04-28 Interventional | 1 | 0 | Abiraterone Ace… Prostatic Neopl… Metastatic Cast… | Study abandoned, no participants enrolled - | |||
| NCT04872608 Details | 2023-04-28 Interventional | 1 | 0 | Letrozole Onapristone Palbociclib Breast Neoplasm… Metastatic Brea… Unresectable Br… | The sponsor closed the study due to discontinuing their onapristone program - | |||
| NCT04348006 Details | 2023-04-28 Interventional | 4 | 0 | Bortezomib Cyclophosphamid… Dexamethasone Lenalidomide Multiple Myelom… Neoplasms, Plas… Newly Diagnosed… | No patients were enrolled in the study - | |||
| NCT03697564 Details | 2023-04-28 Interventional | 2 | - | Gemcitabine Nivolumab Pancreatic Neop… Pancreatic Canc… | Working on getting accurate information for patients interested in the study. - | |||
| NCT00042406 Details | 2023-04-28 Interventional | 2/3 | 83 | Antibodies, Mon… Zanolimumab Arthritis Arthritis, Rheu… Rheumatoid Arth… | - - | |||
| NCT03953677 Details | 2023-04-27 Interventional | 3 | 32 | Dexmedetomidine Pharmaceutical … Shock Shock, Septic Septic Shock Vasopressor Res… | Excess mortality in one arm of the study that led to discontinuation of enrollment - | |||
| NCT03097796 Details | 2023-04-27 Interventional | 1 | 0 | Pam2CSK4 acetat… Hematologic Dis… Stem Cell Trans… | Development plan revised - | |||
| NCT01838174 Details | 2023-04-27 Interventional | 4 | 37 | Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Multiple Sclero… Neuritis Optic Neuritis | Sponsor requested - | |||
| NCT01147016 NCT01658969 Details | 2023-04-27 Interventional | 2 | 8 | Cyclophosphamid… Doxorubicin Liposomal doxor… Paclitaxel Breast Neoplasm… Breast Cancer | Primary co-investigator leaving the institution & funding transfer. - | |||
| NCT03603964 Details | 2023-04-26 Interventional | 2 | 35 | Guadecitabine Acute Myeloid L… Myeloid Dysplas… | Early termination not due to patient safety The study was terminated early not due to participant safety. |